To Continue or Not Continue: Beta-Blockers Following Acute Myocardial Infarction

In the ABYSS trial, interruption of long-term beta-blocker therapy did not reduce the risk of death or adverse cardiovascular events in patients with previous acute myocardial infarction.

Prosthesis-Patient Mismatch and TAVR Outcomes

Does measured or predicted prosthesis-patient mismatch after transcatheter aortic valve replacement affect all-cause mortality at 2 years?

Final CMP Performance Assessment is Now Open

The CMP Performance Assessment (PA) window for cardiovascular disease is open through Dec. 15. To participate, launch your ACCSAP and select the blue CMP Hub. This is your last chance to participate for 2024!

Latest In Cardiology

Products

Engage

Quick Links

Events and Conferences

Join

Memberships

Fellow of the ACC (FACC)

Earn the ultimate recognition. Fellowship identifies you to peers and patients as a cardiovascular professional at the top of your field.

Cardiovascular Team

Join a vibrant community of nurses, PAs, clinical pharmacists, technologists and rehab specialists.

International Associate

Join a global community dedicated to reducing the burden of CV disease worldwide and access resources that help you advance your knowledge and expand your network.

Benefits

Unlock access to all 10 JACC Journals, exclusive networking opportunities with 56,000 cardiovascular professionals, deep discounts on educational opportunities and more.

Learn More  
The ACC is our community to learn from one another and grow with each other. United, we have the ability to advocate for our patients and profession. Nkechinyere Ijioma, MBBS, FACC

ACC Digital Family